BREATH TEST FOR DISEASE DETECTION
COVID-19
Breathonix BreFence™ Go COVID-19 Breath Test System has gained Singapore HSA Provisional Approval.
Other Fatal Diseases
Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis.
KEY HIGHLIGHTS
Slingshot 2019 MedTech Winner
Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition.
6+ Years of Breath Analysis Research
The technology is developed from 6+ years of breath analysis research in National University of Singapore (NUS).
Backed by Reputable Investors
Funded by NUS Enterprise, Origgin and Antler.
COLLABORATION
To the ones who made it possible
JOIN OUR MISSION
Reimagine Diagnostics with Rapid Breath Test for Disease Detection
LATEST UPDATES
SINGAPORE, 16 July 2021 – Singapore-based firms Accredify and Breathonix today announced their collaboration to supply an on-site COVID-19 rapid-breath test system that issues digital verifiable COVID-19 test results compliant with countries’ international travel and domestic health requirements in less than […]
Local conglomerate Vingroup has successfully reached a deal with Singaporean firm Breathonix to bring to Vietnam a COVID-19 breath testing system costing over 460 billion VND (20 million USD). Hanoi (VNA) – Local conglomerate Vingroup has successfully reached a deal with […]
Malaysia-based government services provider MyEG Services has signed a deal with National University of Singapore spin-off Breathonix to provide a rapid breath test system for Covid-19 in Malaysia. Following the memorandum of understanding, MyEG will begin applying for regulatory approvals and certifications for the […]